Guardant Health (GH) Announces Debt Exchange Transactions
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Guardant Health Announces Debt Exchange Transactions
February 7, 2025 6:30 AM ESTPALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on February 6, 2025, it entered into privately negotiated exchange agreements (the Exchange Agreements) with certain holders of its outstanding 0% Convertible Senior Notes due 2027 (the 2027 Notes), pursuant to which the Company will issue $600 million aggregate principal amount of 1.25% Convertible Senior Notes due 2031 (the New Notes) in exchange for the retirement of approximately $659.3 million principal amount of 2027 Notes (the Transactions). The initial conversion rate of the New Notes will be 16.0716 shares of Guardant Healths common stock (the common stock), per $1,000 principal... More
